@ShahidNShah

Before Deploying AI Therapy, Health Systems Should Ask These Six Clinical Questions
Health systems are under pressure to improve mental health access without creating more work for already stretched teams. Conversational AI is attracting attention because it can support patients outside office hours and deliver structured interactions at scale. But a convincing demo does not make an effective care pathway.
For healthcare leaders, the important question is whether the service fits into clinical care, produces measurable benefits, and knows when a human should take over. How naturally it holds a conversation matters far less.
“Mental health AI” covers very different activities: answering questions, helping people enter a referral pathway, supporting structured exercises, and delivering a specific course of care. These are not interchangeable, and a tool intended for general emotional conversation should not automatically be treated as a therapy intervention.
Before procurement, teams should define the intended population, intervention, exclusions, and clinical responsibilities. Vendors increasingly position AI therapy as a structured, clinician-designed service built on methods such as CBT, rather than open-ended chat. That distinction is worth testing in practice: ask to see the protocol, the exclusion criteria, and the clinical sign-off behind each exercise, and confirm which claims are supported by product-specific evidence.
In 2025, Heinz and colleagues published a randomized trial of Therabot in NEJM AI. Among 210 adults, the research team found greater short-term symptom improvement in the intervention group than in a waitlist control. The trial supports the potential of a carefully developed mental health chatbot. It does not show that every conversational system works, or that any of them outperforms a clinician.
Healthcare evaluators should distinguish evidence for a therapeutic technique, an AI model, and the exact service being purchased. They should also examine sample size, comparator, patient selection, follow-up duration, and any reported adverse events.
An AI service may operate outside office hours, but patient risk does not disappear when the clinic closes. Teams need explicit answers about what happens when someone reports worsening symptoms, self-harm concerns, or needs care beyond the tool’s intended scope.
A sound pathway identifies who receives alerts, expected response times, documentation requirements, and what patients are told when urgent help is needed. “Clinician supervised” is useful only when the actual supervision process is documented and tested.
Access is a workflow issue as well as a clinical issue. Requiring an app download, password, or video connection can introduce friction. Some services instead use an ordinary phone call. Limbic’s Unpacked, for instance, offers phone therapy delivered by an AI voice agent that guides structured CBT exercises, with licensed clinicians reviewing patient progress. Teams adopting this kind of model should tell patients plainly that they will be speaking with software, not a human therapist.
The delivery channel matters. In a randomized trial of 325 primary care patients with depression, Mohr and colleagues found that therapist-delivered CBT by telephone had lower dropout than face-to-face CBT. At six months, however, the face-to-face group had better average depression scores. A convenient channel can improve retention without guaranteeing outcomes, and neither finding validates a specific AI voice service.
A deployment scorecard should go beyond completed conversations. Useful measures include time from initial request to support, first-session completion, engagement over time, patient-reported symptoms, escalation rates, patient understanding, and staff workload. Outcomes should be reviewed across demographic groups where appropriate to identify uneven access or safety concerns.
Comparisons need a credible baseline. A service that generates many interactions may still fail if patients do not progress to appropriate treatment or if clinical teams cannot manage alerts.
A responsible deployment includes a clear alternative pathway. Patients may prefer a human therapist, need a different intervention, or lack the privacy required to speak freely. Teams should explain the AI’s role without implying that consent to automated care is the only route to support.
Conversational AI may widen the options available to behavioral health services. Its value depends on specific clinical tasks, appropriately interpreted evidence, usable access, documented escalation, and continuous outcome monitoring. Organizations that evaluate these components before deployment will be better equipped to identify both meaningful benefits and avoidable risks.
Heinz, M. V., Mackin, D. M., Trudeau, B. M., Bhattacharya, S., Wang, Y., Banta, H. A., Jewett, A. D., Salzhauer, A. J., Griffin, T. Z., & Jacobson, N. C. (2025). Randomized trial of a generative AI chatbot for mental health treatment. NEJM AI, 2(4), AIoa2400802. https://doi.org/10.1056/AIoa2400802
Mohr, D. C., Ho, J., Duffecy, J., Reifler, D., Sokol, L., Burns, M. N., Jin, L., & Siddique, J. (2012). Effect of telephone-administered vs face-to-face cognitive behavioral therapy on adherence to therapy and depression outcomes among primary care patients: A randomized trial. JAMA, 307(21), 2278–2285. https://doi.org/10.1001/jama.2012.5588
Jephonie Villegas is a Bachelor of Science in Nursing graduate with more than a decade of experience in content writing and digital technology. Her work makes complex healthcare topics more accessible, with an emphasis on evidence, patient safety and the practical considerations involved in evaluating emerging technology. She works with Limbic, a clinical AI company. Disclosure: Limbic offers Unpacked, the service mentioned in this article.
Snoring is often treated as a joke or a nuisance for the person lying next to you. It is better seen as a sign about how you breathe at night. For many people the problem starts in the nose. When the …
Posted Nov 16, 2026 Health Technology
Connecting innovation decision makers to authoritative information, institutions, people and insights.
Medigy accurately delivers healthcare and technology information, news and insight from around the world.
Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.
© 2026 Netspective Foundation, Inc. All Rights Reserved.
Built on Nov 16, 2026 at 6:06pm